• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国东南部福建省苯丙氨酸羟化酶缺乏症患者的苯丙氨酸羟化酶基因突变特征及基因型-表型相关性分析。

Characterization of phenylalanine hydroxylase gene variants and analysis of genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Fujian Province, Southeastern China.

机构信息

Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, Fujian Province, China.

Obstetrics and Gynecology Department, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, Fujian Province, China.

出版信息

Mol Biol Rep. 2022 Nov;49(11):10409-10419. doi: 10.1007/s11033-022-07579-8. Epub 2022 Sep 14.

DOI:10.1007/s11033-022-07579-8
PMID:36104584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9618490/
Abstract

BACKGROUND

Phenylalanine hydroxylase deficiency (PAHD) is the most prevalent inherited disorder of amino acid metabolism in China. Its complex phenotype includes many variants and genotypes among different populations.

METHODS AND RESULTS

In this study, we analyzed the phenylalanine hydroxylase gene (PAH) variants in a cohort of 93 PAHD patients from Fujian Province. We also assessed genotype and phenotype correlation in patients with PAHD. A total of 44 different pathogenic variants were identified, including five novel variants. The three most prevalent variants among all patents were c.158G > A, p.(Arg53His) (18.03%), c.721C > T, p.(Arg241Cys) (14.75%), and c.728G > A, p.(Arg243Gln) (7.65%). The frequency of the c.158G > A, p.(Arg53His) variant was highest in patients with mild hyperphenylalaninemia, whereas the frequency of the c.1197A > T, p.(Val399 =) and c.331C > T, p.(Arg111Ter) variants was highest in patients with classic phenylketonuria. The most abundant genotypes observed in PAHD patients were c.[158G > A];[728G > A], c.[158G > A];[442-1G > A], and c.[158G > A];[721C > T]. Comparing allelic phenotype to genotypic phenotype values yielded fairly accurate predictions of phenotype, with an overall consistency rate was 85.71% for PAHD patients.

CONCLUSIONS

Our study identified a PAH variant spectrum in PAHD patients from Fujian Province, Southeastern China. Quantitative correlation analysis between genotype and phenotype severity is helpful for genetic counseling and management.

摘要

背景

苯丙氨酸羟化酶缺乏症(PAHD)是中国最常见的氨基酸代谢遗传障碍。其复杂表型在不同人群中存在多种变异和基因型。

方法和结果

本研究分析了来自福建省的 93 例 PAHD 患者的苯丙氨酸羟化酶基因(PAH)变异。还评估了 PAHD 患者的基因型和表型相关性。共鉴定出 44 种不同的致病性变异,包括 5 种新变异。所有患者中最常见的三个变异是 c.158G>A、p.(Arg53His)(18.03%)、c.721C>T、p.(Arg241Cys)(14.75%)和 c.728G>A、p.(Arg243Gln)(7.65%)。c.158G>A、p.(Arg53His) 变异在轻度高苯丙氨酸血症患者中的频率最高,而 c.1197A>T、p.(Val399=)和 c.331C>T、p.(Arg111Ter) 变异在经典苯丙酮尿症患者中的频率最高。PAHD 患者最常见的基因型是 c.[158G>A];[728G>A]、c.[158G>A];[442-1G>A]和 c.[158G>A];[721C>T]。将等位基因表型与基因型表型值进行比较,对表型进行了相当准确的预测,PAHD 患者的总体一致性率为 85.71%。

结论

本研究在中国东南部福建省的 PAHD 患者中确定了 PAH 变异谱。基因型与表型严重程度的定量相关性分析有助于遗传咨询和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9722/9618490/fc9f02417a3b/11033_2022_7579_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9722/9618490/fc9f02417a3b/11033_2022_7579_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9722/9618490/fc9f02417a3b/11033_2022_7579_Fig1_HTML.jpg

相似文献

1
Characterization of phenylalanine hydroxylase gene variants and analysis of genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Fujian Province, Southeastern China.中国东南部福建省苯丙氨酸羟化酶缺乏症患者的苯丙氨酸羟化酶基因突变特征及基因型-表型相关性分析。
Mol Biol Rep. 2022 Nov;49(11):10409-10419. doi: 10.1007/s11033-022-07579-8. Epub 2022 Sep 14.
2
Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Shanxi province.山西省苯丙氨酸羟化酶缺乏症患者的 PAH 基因突变谱及基因型-表型相关性。
Brain Dev. 2021 Feb;43(2):220-229. doi: 10.1016/j.braindev.2020.08.012. Epub 2020 Sep 4.
3
Mutational spectrum of phenylketonuria in Jiangsu province.江苏省苯丙酮尿症的突变谱
Eur J Pediatr. 2015 Oct;174(10):1333-8. doi: 10.1007/s00431-015-2539-z. Epub 2015 Apr 19.
4
[Analysis of pathogenicity and genotype-phenotype correlation of the c.158G>A variant of phenylalanine hydroxylase gene].[苯丙氨酸羟化酶基因c.158G>A变异的致病性及基因型-表型相关性分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024 Mar 10;41(3):278-283. doi: 10.3760/cma.j.cn511374-20210623-00532.
5
Mutational and phenotypic spectrum of phenylalanine hydroxylase deficiency in Zhejiang Province, China.中国浙江省苯丙氨酸羟化酶缺乏症的突变和表型谱。
Sci Rep. 2018 Nov 20;8(1):17137. doi: 10.1038/s41598-018-35373-9.
6
Mutation spectrum of PAH gene in phenylketonuria patients in Northwest China: identification of twenty novel variants.中国西北地区苯丙酮尿症患者 PAH 基因突变谱:二十种新变异的鉴定。
Metab Brain Dis. 2019 Jun;34(3):733-745. doi: 10.1007/s11011-019-0387-7. Epub 2019 Feb 12.
7
Screening and mutation analysis of phenylalanine hydroxylase deficiency in newborns from Jiangxi province.江西省新生儿苯丙氨酸羟化酶缺乏症的筛查与突变分析
Front Genet. 2023 Feb 9;14:1049816. doi: 10.3389/fgene.2023.1049816. eCollection 2023.
8
Variants of the phenylalanine hydroxylase gene in neonates with phenylketonuria in Hainan, China.中国海南苯丙酮尿症新生儿苯丙氨酸羟化酶基因变异。
Scand J Clin Lab Invest. 2020 Dec;80(8):619-622. doi: 10.1080/00365513.2020.1827287. Epub 2020 Nov 9.
9
Variations in genotype-phenotype correlations in phenylalanine hydroxylase deficiency in Chinese Han population.中国汉族人群苯丙氨酸羟化酶缺乏症基因型-表型相关性的变异。
Gene. 2013 Oct 15;529(1):80-7. doi: 10.1016/j.gene.2013.07.079. Epub 2013 Aug 7.
10
[Genotype and phenotype correlation of phenylalanine hydroxylase deficiency among patients from Henan].[河南患者苯丙氨酸羟化酶缺乏症的基因型与表型相关性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Jun;33(3):300-5. doi: 10.3760/cma.j.issn.1003-9406.2016.03.005.

引用本文的文献

1
The influence of hypertensive disorders in pregnancy on neonatal amino acid and acylcarnitine levels.妊娠期高血压疾病对新生儿氨基酸和酰基肉碱水平的影响。
Front Nutr. 2025 Aug 15;12:1520262. doi: 10.3389/fnut.2025.1520262. eCollection 2025.
2
Spectrum analysis of inborn errors of metabolism for expanded newborn screening in Xinjiang, China.中国新疆扩大新生儿筛查中先天性代谢缺陷的光谱分析
PeerJ. 2024 Dec 9;12:e18173. doi: 10.7717/peerj.18173. eCollection 2024.
3
Biochemical and molecular features of tetrahydrobiopterin deficiency in Fujian Province, southeastern China.

本文引用的文献

1
Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation.动物模型对高苯丙氨酸血症病理生理学的研究进展:线粒体功能障碍、氧化应激和炎症的作用。
Mol Neurobiol. 2021 Jun;58(6):2897-2909. doi: 10.1007/s12035-021-02304-1. Epub 2021 Feb 6.
2
Phenylketonuria in Portugal: Genotype-phenotype correlations using molecular, biochemical, and haplotypic analyses.葡萄牙苯丙酮尿症:基于分子、生化和单体型分析的基因型-表型相关性。
Mol Genet Genomic Med. 2021 Mar;9(3):e1559. doi: 10.1002/mgg3.1559. Epub 2021 Jan 19.
3
Variants of the phenylalanine hydroxylase gene in neonates with phenylketonuria in Hainan, China.
中国东南部福建省四氢生物蝶呤缺乏症的生化和分子特征
Front Genet. 2023 Aug 11;14:1250568. doi: 10.3389/fgene.2023.1250568. eCollection 2023.
4
Biochemical and molecular features of chinese patients with glutaric acidemia type 1 from Fujian Province, southeastern China.中国东南部福建省 1 型戊二酸血症患者的生化和分子特征。
Orphanet J Rare Dis. 2023 Jul 26;18(1):215. doi: 10.1186/s13023-023-02833-z.
5
Screening and mutation analysis of phenylalanine hydroxylase deficiency in newborns from Jiangxi province.江西省新生儿苯丙氨酸羟化酶缺乏症的筛查与突变分析
Front Genet. 2023 Feb 9;14:1049816. doi: 10.3389/fgene.2023.1049816. eCollection 2023.
6
Identification of proline-rich protein 11 as a major regulator in mouse spermatogonia maintenance via an increase in BMI1 protein stability.鉴定脯氨酸丰富蛋白 11 为小鼠精原细胞维持的主要调控因子,通过增加 BMI1 蛋白稳定性。
Mol Biol Rep. 2022 Oct;49(10):9555-9564. doi: 10.1007/s11033-022-07846-8. Epub 2022 Aug 18.
中国海南苯丙酮尿症新生儿苯丙氨酸羟化酶基因变异。
Scand J Clin Lab Invest. 2020 Dec;80(8):619-622. doi: 10.1080/00365513.2020.1827287. Epub 2020 Nov 9.
4
Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Shanxi province.山西省苯丙氨酸羟化酶缺乏症患者的 PAH 基因突变谱及基因型-表型相关性。
Brain Dev. 2021 Feb;43(2):220-229. doi: 10.1016/j.braindev.2020.08.012. Epub 2020 Sep 4.
5
Genetic variants of the phenylalanine hydroxylase gene in patients with phenylketonuria in the northeast of Iran.伊朗东北部苯丙酮尿症患者苯丙氨酸羟化酶基因的遗传变异
J Pediatr Endocrinol Metab. 2020 Mar 26;33(3):355-359. doi: 10.1515/jpem-2019-0351.
6
Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center study.美国苯丙氨酸羟化酶基因型-表型相关性:一项单中心研究。
Mol Genet Metab. 2019 Dec;128(4):415-421. doi: 10.1016/j.ymgme.2019.09.004. Epub 2019 Sep 14.
7
Evaluation of droplet digital PCR for non-invasive prenatal diagnosis of phenylketonuria.评估液滴数字 PCR 用于苯丙酮尿症的无创性产前诊断。
Anal Bioanal Chem. 2019 Nov;411(27):7115-7126. doi: 10.1007/s00216-019-02087-4. Epub 2019 Sep 4.
8
Noninvasive fetal genotyping in pregnancies at risk for PKU using a comprehensive quantitative cSMART assay for PAH gene mutations: a clinical feasibility study.利用 PAH 基因突变的综合定量 cSMART 检测对患有 PKU 风险的妊娠进行无创性胎儿基因分型:一项临床可行性研究。
BJOG. 2019 Nov;126(12):1466-1474. doi: 10.1111/1471-0528.15869. Epub 2019 Aug 16.
9
In vitro residual activities in 20 variants of phenylalanine hydroxylase and genotype-phenotype correlation in phenylketonuria patients.苯丙氨酸羟化酶 20 种变异体的体外残留活性与苯丙酮尿症患者基因型-表型相关性分析。
Gene. 2019 Jul 30;707:239-245. doi: 10.1016/j.gene.2019.05.029. Epub 2019 May 15.
10
Phenylketonuria: Current Treatments and Future Developments.苯丙酮尿症:现有治疗方法与未来发展。
Drugs. 2019 Apr;79(5):495-500. doi: 10.1007/s40265-019-01079-z.